Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Placebo-Controlled, Crossover Study of the Safety and Effectiveness of Subcutaneous Injections of Apomorphine in the Treatment of "Off" Episodes in Patients With "On/Off" or "Wearing Off" Effects Associated With Late Stage Parkinson's Disease

NCT00200512 is registered in ClinicalTrials.gov with Mylan Bertek Pharmaceuticals as lead sponsor.

NCT NCT00200512
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00200512 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Placebo-Controlled, Crossover Study of the Safety and Effectiveness of Subcutaneous Injections of Apomorphine in the Treatment of "Off" Episodes in Patients With "On/Off" or "Wearing Off" Effects Associated With Late Stage Parkinson's Disease
Lead sponsor
Mylan Bertek Pharmaceuticals
Phase
Phase 2/3
Overall status
Completed
Start date
September 30, 1999
Completion date
November 30, 1999
Enrollment
16
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease